Position in MRVI
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$1,011,044
-$367,949 QoQ
Shares Held
357,260
-15.8% QoQ
Ownership
0.138%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 87.35262833790517.ToString("F0")%
Shared 0.ToString("F0")%
None 12.647371662094834.ToString("F0")%
Common Shares in MRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026JPMORGAN CHASE & CO holds $16,578,634,665 across 404 Biotechnology names. MRVI ranks #173 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
24,150,499 | $3,949,089,591 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,311,806 | $3,331,473,778 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,033,156 | $3,140,585,469 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
6,323,752 | $2,092,339,815 | |
| 5 | NUVL |
Nuvalent, Inc.
|
3,088,349 | $316,401,351 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,204,353 | $227,682,931 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
2,363,567 | $177,480,242 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
2,869,728 | $151,292,056 |
All Filings in MRVI
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,011,044 | 357,260 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $1,378,993 | 424,306 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $774,316 | 269,797 | Shares | Defined | 2025-11-26 | |
| 2025-06-30 | $860,083 | 356,882 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $1,498,790 | 678,187 | Shares | Other | 2025-05-12 | |
| 2024-12-31 | $23,166,072 | 4,250,656 | Shares | Other | 2025-02-12 | |
| 2024-09-30 | $33,657,532 | 4,050,245 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $2,279,176 | 318,321 | Shares | Other | 2024-12-26 | |
| 2024-03-31 | $4,133,611 | 476,772 | Shares | Other | 2024-12-26 | |
| 2023-12-31 | $2,459,968 | 375,568 | Shares | Other | 2024-12-26 | |
| 2023-09-30 | $3,197,400 | 319,740 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $4,075,085 | 327,843 | Shares | Other | 2023-08-11 | |
| 2023-03-31 | $54,505,580 | 3,890,477 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $55,966,865 | 3,911,032 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $91,519,228 | 3,584,772 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $100,303,235 | 3,530,561 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $119,727,541 | 3,394,600 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $147,119,570 | 3,511,207 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $194,678,517 | 3,966,555 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $203,723,812 | 4,881,951 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $156,232,821 | 4,383,637 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $116,154,740 | 4,140,989 | Shares | Defined | 2021-02-19 | |
| No filing history on record for this holder in this stock. | ||||||